
HT Capital
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Asset Management, Venture Capital, Fund of Funds
Investor Profile
HT Capital has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, China, Japan.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series B (33%)
- Series C (25%)
- Series Unknown (17%)
- Series A (17%)
- Series D (8%)
Country Focus
- United States (50%)
- China (33%)
- Japan (8%)
- Israel (8%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Autonomous Vehicles
- Manufacturing
- Therapeutics
- Biopharma
- Pharmaceutical
- Commercial
- Apps
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does HT Capital frequently co-invest with?
Which angels does HT Capital often collaborate with?
What are some of recent deals done by HT Capital?
Find More Investors Like HT Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









